4.7 Review

GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 39, Issue 9, Pages 798-811

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2018.07.002

Keywords

-

Funding

  1. National Key R&D program of China [2018YFA0507403]
  2. NSFC [31770991, 91742202, 81525013, 81722022, 81788101]
  3. Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29030000]
  4. Young Talent Support Program
  5. Fundamental Research Funds for the Central Universities

Ask authors/readers for more resources

The NLRP3 inflammasome is an intracellular multimeric protein complex which plays an important role in the pathogenesis of various human inflammatory diseases, such as diabetes, Alzheimer's disease and atherosclerosis. Recently, various G protein-coupled receptors (GPCRs) have been reported to be involved in the activation and regulation of the NLRP3 inflammasome by sensing multiple ions, metabolites, and neurotransmitters, suggesting GPCR signaling is an important regulator for NLRP3 inflammasome. Here, we will review how various GPCRs promote or inhibit NLRP3 inflammasome activation and discuss the implications of GPCRs as drug targets for the therapy of NLRP3-driven diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available